#None #Avian Influenza #Alveo Technologies #Alliance Global

Alveo Technologies Partners with Alliance Global for Avian Influenza Testing Accessibility

Introduction
In a strategic move to combat the spread of avian influenza, Alveo Technologies has joined forces with Alliance Global (AGBL) to expand access to its rapid molecular diagnostic testing technology across Africa, Central Asia, and a select portion of the Eastern Mediterranean. This partnership aims to safeguard poultry health and enhance public safety in the context of an escalating global avian influenza crisis.

The Urgency of Avian Influenza Outbreaks
Recent statistics reveal a disturbing escalation of avian influenza cases, with over 208 million domestic birds affected in the United States alone and a staggering 633 million worldwide. The ramifications of such outbreaks extend beyond the agricultural sector to pose significant threats to food supply chains and the livelihoods of farmers. Rapid testing at the site of infection becomes essential, enabling farmers and health officials to take immediate action to prevent the spread of the virus and protect both flocks and workers.

Details of the Distribution Agreement
The newly minted distribution agreement grants AGBL rights to disseminate the Alveo Sense Poultry avian influenza test throughout the specified regions. This collaboration merges Alveo's innovative, portable diagnostic technology with AGBL's established regional network and operational capabilities, bringing a timely solution to pressing public health challenges. Alveo’s diagnostic equipment allows for on-site testing, ensuring that farmers can swiftly determine the health status of their flocks without the delays associated with transporting samples to far-off laboratories.

Benefits for Agriculture and Public Health
Scott Thomas, the Chief Commercial Officer at Alveo Technologies, expressed confidence about the partnership’s potential impact: “AGBL's reach into Africa, Central Asia, and the Eastern Mediterranean gives us a direct line to farmers, integrators, and public health officials who require reliable avian influenza testing amid ongoing outbreaks.” This statement underscores the partnership’s goal to help recognize and respond to outbreaks swiftly, thereby protecting agricultural communities that rely heavily on healthy poultry populations for food security and economic stability.

Nassim Marie Hambouz, Vice President of Operations at AGBL, emphasized the need for rapid and accurate testing. “Farmers, public health officials, and others in these regions need a rapid assessment method for avian influenza in their flocks to take immediate defensive measures,” Hambouz noted, demonstrating AGBL's commitment to equipping communities with critical diagnostic capabilities.

Global Availability and Future Aspirations
This agreement not only increases the availability of the Alveo Sense Poultry platform but also signals the company’s ongoing efforts to establish a global commercial network. By utilizing AGBL’s extensive infrastructure, Alveo Technologies can enhance its service reach while bolstering the testing capacity crucial for addressing avian influenza risks effectively. The development comes as part of Alveo’s broader mission to decentralize molecular diagnostics and enable real-time decision-making.

About Alveo Technologies and Alliance Global
Alveo Technologies is a leading molecular diagnostics firm specializing in developing portable diagnostic solutions for early disease detection. Their product portfolio includes state-of-the-art tests for avian influenza and other significant pathogens, emphasizing rapid detection at the point of need. Meanwhile, Alliance Global is recognized as the foremost biomedical distribution group across the Middle East, Africa, and Asia, providing innovative healthcare technologies and services aimed at improving diagnosis and public health outcomes in emerging markets.

Conclusion
As global concerns surrounding avian influenza grow, partnerships like this one between Alveo Technologies and Alliance Global are pivotal. By improving access to rapid testing, the collaboration aims to empower agricultural sectors and public health stakeholders to act proactively against the spread of disease, ensuring the safety and health of communities reliant on poultry farming. The initiative reflects a significant step toward enhancing the resilience of food supply chains and public health frameworks amidst an evolving landscape of infectious disease threats.

For additional information, please visit Alveo Technologies' official website for updates about their revolutionary testing solutions and ongoing partnerships.